Baker Tilly Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$311K Sell
591
-87
-13% -$48.8K 0.07% 216
2026
Q1
$381K Sell
678
-133
-16% -$85.3K 0.09% 183
2025
Q4
$549K Sell
811
-53
-6% -$36.1K 0.14% 149
2025
Q3
$552K Buy
864
+61
+8% +$37K 0.12% 140
2025
Q2
$431K Buy
803
+227
+39% +$109K 0.15% 139
2025
Q1
$242K Buy
+576
New +$250K 0.09% 211
2024
Q4
Sell
-438
Closed -$221K 244
2024
Q3
$221K Buy
+438
New +$213K 0.1% 221
2024
Q2
Sell
-373
Closed -$201K 341
2024
Q1
$201K Buy
+373
New +$204K 0.04% 407
2023
Q3
Sell
-1,647
Closed -$827K 509
2023
Q2
$827K Sell
1,647
-28
-2% -$13.4K 0.09% 234
2023
Q1
$838K Sell
1,675
-232
-12% -$111K 0.09% 230
2022
Q4
$778K Buy
1,907
+466
+32% +$181K 0.1% 234
2022
Q3
$469K Buy
1,441
+181
+14% +$66.5K 0.06% 305
2022
Q2
$442K Sell
1,260
-109
-8% -$44.4K 0.06% 338
2022
Q1
$749K Buy
1,369
+807
+144% +$425K 0.08% 244
2021
Q4
$370K Buy
562
+77
+16% +$48.3K 0.04% 403
2021
Q3
$302K Buy
485
+48
+11% +$32.3K 0.04% 419
2021
Q2
$276K Hold
437
0.04% 414
2021
Q1
$214K Buy
+437
New +$219K 0.04% 436

Other funds holding IDXX

Baker Tilly Wealth Management's IDXX Position: Q2 2026 in Review

Baker Tilly Wealth Management reduced its Idexx Laboratories (IDXX) stake by 13% in Q2 2026, selling an estimated $48.8K and leaving 591 shares worth $311K. The position accounts for 0.07% of the portfolio, ranked #216.

Baker Tilly Wealth Management first reported a position in IDXX in Q1 2021 and has held it in 18 quarters since. The position peaked at $838K in Q1 2023. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Baker Tilly Wealth Management held 591 shares of Idexx Laboratories worth $311K as of Q2 2026.
  • Baker Tilly Wealth Management sold 87 Idexx Laboratories shares in Q2 2026, an estimated $48.8K.
  • Idexx Laboratories made up 0.07% of Baker Tilly Wealth Management's portfolio in Q2 2026, its #216 holding.
  • Baker Tilly Wealth Management first reported a position in Idexx Laboratories in Q1 2021 and has held it in 18 quarters since.
  • Baker Tilly Wealth Management's Idexx Laboratories position peaked at $838K in Q1 2023.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Baker Tilly Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.